☆B Group, Inc.
Quality Q
0.476
AUM ($M)
176
Positions
18
Turnover
0.17
Top-10 wt
79%
Herfindahl
0.083
History (qtrs)
6
Excess Return
not eligible
AI Eval Run AI Eval
Holdings · 21 positions · portfolio value $176M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆ADMA funds › | ADMA BIOLOGICS INC | ADD | Common Stock | 15.5% | -5.9% | 27.3 | 3,262,542 | +55,000 | 5 | — |
| ☆PALI funds › | PALISADE BIO INC | HOLD | — | 13.5% | -1.3% | 23.9 | 11,414,285 | +0 | 3 | — |
| ☆NRXP funds › | NRX PHARMACEUTICALS INC | ADD | — | 9.5% | +4.8% | 16.7 | 4,091,767 | +1,091,767 | 2 | — |
| ☆FTH funds › | FAETH THERAPEUTICS INC | NEW | — | 8.7% | +8.7% | 15.3 | 610,169 | +610,169 | 1 | — |
| ☆TSHA funds › | TAYSHA GENE THERAPIES INC | HOLD | — | 7.0% | +1.0% | 12.3 | 1,800,556 | +0 | 5 | — |
| ☆PRAX funds › | PRAXIS PRECISION MEDICINES I | HOLD | — | 6.3% | -1.6% | 11.1 | 33,237 | +0 | 5 | — |
| ☆CLLS funds › | CELLECTIS S A | HOLD | — | 5.6% | -2.1% | 9.8 | 3,281,501 | +0 | 5 | — |
| ☆ZLAB funds › | ZAI LAB LTD | HOLD | — | 4.9% | -1.4% | 8.6 | 450,646 | +0 | 5 | — |
| ☆GPCR funds › | STRUCTURE THERAPEUTICS INC | ADD | — | 4.3% | -0.3% | 7.5 | 140,000 | +12,500 | 3 | — |
| ☆ORKA funds › | ORUKA THERAPEUTICS INC | HOLD | — | 4.1% | +1.3% | 7.1 | 75,000 | +0 | 5 | — |
| ☆IOVA funds › | IOVANCE BIOTHERAPEUTICS INC | HOLD | — | 3.5% | -0.4% | 6.2 | 1,500,000 | +0 | 5 | — |
| ☆SYRE funds › | SPYRE THERAPEUTICS INC | TRIM | — | 3.5% | -0.2% | 6.2 | 70,000 | -30,000 | 5 | — |
| ☆AURA funds › | AURA BIOSCIENCES INC | ADD | — | 3.1% | +0.1% | 5.4 | 764,243 | +166,667 | 5 | — |
| ☆ASMB funds › | ASSEMBLY BIOSCIENCES INC | HOLD | — | 2.7% | -0.9% | 4.8 | 175,706 | +0 | 5 | — |
| ☆DRUG funds › | BRIGHT MINDS BIOSCIENCES INC | HOLD | — | 2.7% | -1.0% | 4.7 | 67,500 | +0 | 2 | — |
| ☆RARE funds › | ULTRAGENYX PHARMACEUTICAL IN | HOLD | — | 2.6% | +0.5% | 4.5 | 135,000 | +0 | 5 | — |
| ☆SGHT funds › | SIGHT SCIENCES INC | HOLD | — | 2.1% | -0.6% | 3.7 | 970,000 | +0 | 5 | — |
| ☆FHTX funds › | FOGHORN THERAPEUTICS INC | ADD | — | 0.6% | +0.2% | 1.0 | 200,000 | +98,000 | 2 | — |
| ☆REPL funds › | REPLIMUNE GROUP INC | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -26,000 | 0 | — |
| ☆APGE funds › | APOGEE THERAPEUTICS INC | EXIT | — | 0.0% | -0.5% | 0.0 | 0 | -7,500 | 0 | — |
| ☆CUSIP:834203309 funds › | SOLENO THERAPEUTICS INC | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -7,500 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 176 | 18 | 0.17 | 79% | 0.083 | 0.476 | — | in |
| 2026Q1 | 135 | 20 | 0.22 | 81% | 0.100 | 0.362 | — | in |
| 2025Q4 | 135 | 15 | 0.26 | 90% | 0.154 | 0.310 | — | in |
| 2025Q3 | 105 | 17 | 0.16 | 91% | 0.163 | 0.478 | — | in |
| 2025Q2 | 116 | 15 | 0.12 | 93% | 0.185 | 0.656 | — | entered |
| 2025Q1 | 115 | 17 | 0.00 | 94% | 0.218 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status